| scholarly article | Q13442814 |
| P50 | author | Michael Saag | Q6834090 |
| Suzanne Ingle | Q58298008 | ||
| Jonathan Sterne | Q58298018 | ||
| Fiona C Lampe | Q62006742 | ||
| Heidi M. Crane | Q88330348 | ||
| Antonella d'Arminio Monforte | Q42206554 | ||
| Amy C Justice | Q42395670 | ||
| Amanda Mocroft | Q47006497 | ||
| Gerd Fätkenheuer | Q47006694 | ||
| Michael John Gill | Q56334589 | ||
| Julia del Amo | Q56524065 | ||
| François Dabis | Q56850448 | ||
| Matthias Cavassini | Q30004177 | ||
| Dominique Costagliola | Q33104294 | ||
| Robert S Hogg | Q37837778 | ||
| P2093 | author name string | Frank de Wolf | |
| Margaret T May | |||
| Hans-Reinhard Brodt | |||
| Timothy R Sterling | |||
| Jordi Casabona | |||
| Jodie Guest | |||
| Antiretroviral Cohort Collaboration | |||
| P2860 | cites work | Incidence of Tuberculosis among HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy in Europe and North America | Q21521430 |
| AIDS events among individuals initiating HAART: do some patients experience a greater benefit from HAART than others? | Q57181143 | ||
| When to start treatment? A systematic approach to the comparison of dynamic regimes using observational data | Q59855652 | ||
| The changing incidence of AIDS events in patients receiving highly active antiretroviral therapy | Q38959208 | ||
| British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012. | Q44456185 | ||
| Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries | Q46391119 | ||
| British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy. | Q53916718 | ||
| Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies | Q24597052 | ||
| Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies | Q24656950 | ||
| Development and validation of a prognostic model for survival time data: application to prognosis of HIV positive patients treated with antiretroviral therapy | Q30947115 | ||
| Prognostic model for HIV-1 disease progression in patients starting antiretroviral therapy was validated using independent data | Q31005220 | ||
| Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group. | Q34068078 | ||
| Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies | Q34139859 | ||
| Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies | Q34228103 | ||
| Effect of baseline CD4 cell counts on the clinical significance of short-term immunologic response to antiretroviral therapy in individuals with virologic suppression | Q34546011 | ||
| Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equal | Q34546056 | ||
| HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis | Q34554560 | ||
| Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries | Q35057962 | ||
| Prognosis of patients treated with cART from 36 months after initiation, according to current and previous CD4 cell count and plasma HIV-1 RNA measurements | Q35065073 | ||
| Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes | Q35111146 | ||
| Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies | Q35169664 | ||
| Comparative effectiveness of initial antiretroviral therapy regimens: ACTG 5095 and 5142 clinical trials relative to ART-CC cohort study | Q35386113 | ||
| Prognostic importance of anaemia in HIV type-1-infected patients starting antiretroviral therapy: collaborative analysis of prospective cohort studies. | Q35867142 | ||
| The effect of injecting drug use history on disease progression and death among HIV-positive individuals initiating combination antiretroviral therapy: collaborative cohort analysis | Q35962516 | ||
| Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies | Q36285986 | ||
| Heterogeneity in outcomes of treated HIV-positive patients in Europe and North America: relation with patient and cohort characteristics | Q36505229 | ||
| Considerations in the rationale, design and methods of the Strategic Timing of AntiRetroviral Treatment (START) study | Q36875697 | ||
| Tuberculosis after initiation of antiretroviral therapy in low-income and high-income countries | Q36942918 | ||
| Importance of baseline prognostic factors with increasing time since initiation of highly active antiretroviral therapy: collaborative analysis of cohorts of HIV-1-infected patients | Q36943004 | ||
| Does short-term virologic failure translate to clinical events in antiretroviral-naïve patients initiating antiretroviral therapy in clinical practice? | Q37475726 | ||
| Higher rates of AIDS during the first year of antiretroviral therapy among migrants: the importance of tuberculosis | Q37711305 | ||
| P433 | issue | 3 | |
| P921 | main subject | collaboration | Q1145523 |
| anti-retroviral agent | Q50430310 | ||
| P304 | page(s) | 691-702 | |
| P577 | publication date | 2013-04-18 | |
| P1433 | published in | International Journal of Epidemiology | Q6051393 |
| P1476 | title | Cohort profile: Antiretroviral Therapy Cohort Collaboration (ART-CC). | |
| P478 | volume | 43 |
| Q35589775 | A Comparison of Seven Cox Regression-Based Models to Account for Heterogeneity Across Multiple HIV Treatment Cohorts in Latin America and the Caribbean |
| Q57151233 | AIDS Therapy Evaluation in the Netherlands (ATHENA) national observational HIV cohort: cohort profile |
| Q38936312 | Aging of the Liver: What This Means for Patients with HIV. |
| Q35998519 | Alcohol-Related Diagnoses and All-Cause Hospitalization Among HIV-Infected and Uninfected Patients: A Longitudinal Analysis of United States Veterans from 1997 to 2011. |
| Q47644937 | Antiretroviral pill count and clinical outcomes in treatment-naïve patients with HIV infection |
| Q42565458 | Authors' reply: immunodeficiency at the start of combination antiretroviral therapy: steady improvement or step changes? |
| Q40043083 | CD4:CD8 Ratio and CD8 Count as Prognostic Markers for Mortality in Human Immunodeficiency Virus-Infected Patients on Antiretroviral Therapy: The Antiretroviral Therapy Cohort Collaboration (ART-CC). |
| Q38812561 | Cancer Survivor Study (CASUS) on colorectal patients: longitudinal study on physical activity, fitness, nutrition, and its influences on quality of life, disease recurrence, and survival. Rationale and design |
| Q45981767 | Cancer burden attributable to cigarette smoking among HIV-infected people in North America. |
| Q89463361 | Cause-specific mortality after diagnosis of cancer among HIV-positive patients: A collaborative analysis of cohort studies |
| Q40444741 | Cohort Profile: Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord. |
| Q42236353 | Cohort Profile: French hospital database on HIV (FHDH-ANRS CO4). |
| Q48052969 | Cohort Profile: The HIV Atlanta Veterans Affairs Cohort Study (HAVACS). |
| Q33691666 | Cohort profile: seek, test, treat and retain United States criminal justice cohort |
| Q47547280 | Cohort profile: the Comparative Outcomes And Service Utilization Trends (COAST) Study among people living with and without HIV in British Columbia, Canada |
| Q50041539 | Collaborative, pooled and harmonized study designs for epidemiologic research: challenges and opportunities. |
| Q35925705 | Commentary: Questioning the HIV-AIDS Hypothesis: 30 Years of Dissent |
| Q28391248 | Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015 |
| Q91918090 | Factors influencing harmonized health data collection, sharing and linkage in Denmark and Switzerland: A systematic review |
| Q54480924 | GBD 2015 and HIV estimates from the Optima model - Authors' reply. |
| Q40089833 | HIV infection, antiretroviral therapy, and measures of endothelial function, inflammation, metabolism, and oxidative stress |
| Q35149265 | HIV-Care Outcome in Saudi Arabia; a Longitudinal Cohort |
| Q57297481 | Identifying Risk of Viral Failure in Treated HIV-Infected Patients Using Different Measures of Adherence: The Antiretroviral Therapy Cohort Collaboration |
| Q33816061 | Impact of risk factors for specific causes of death in the first and subsequent years of antiretroviral therapy among HIV-infected patients |
| Q47655423 | Increased non-AIDS mortality among persons with AIDS-defining events after antiretroviral therapy initiation |
| Q35864236 | Injection Drug Use and Hepatitis C as Risk Factors for Mortality in HIV-Infected Individuals: The Antiretroviral Therapy Cohort Collaboration |
| Q36919443 | Insurability of HIV-positive people treated with antiretroviral therapy in Europe: collaborative analysis of HIV cohort studies |
| Q26471480 | Interventions for tobacco use cessation in people living with HIV and AIDS |
| Q54219247 | Long-term trends in CD4 cell counts, CD8 cell counts, and the CD4: CD8 ratio: ART Cohort Collaboration (ART-CC) Study. |
| Q36948126 | Mortality According to CD4 Count at Start of Combination Antiretroviral Therapy Among HIV-infected Patients Followed for up to 15 Years After Start of Treatment: Collaborative Cohort Study |
| Q34155253 | Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studies |
| Q36458517 | Mortality of treated HIV-1 positive individuals according to viral subtype in Europe and Canada: collaborative cohort analysis |
| Q95790980 | Parameter estimates for trends and patterns of excess mortality among persons on antiretroviral therapy in high-income European settings |
| Q34823231 | Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America |
| Q38895882 | Structure and quality of outpatient care for people living with an HIV infection |
| Q38401028 | Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies |
| Q34609382 | The effects of HIV-1 subtype and ethnicity on the rate of CD4 cell count decline in patients naive to antiretroviral therapy: a Canadian-European collaborative retrospective cohort study |
| Q35882896 | Using observational data to emulate a randomized trial of dynamic treatment-switching strategies: an application to antiretroviral therapy |
Search more.